InvestorsHub Logo
Followers 86
Posts 4490
Boards Moderated 2
Alias Born 06/22/2006

Re: None

Saturday, 06/08/2013 6:24:47 AM

Saturday, June 08, 2013 6:24:47 AM

Post# of 24848
SCRC.... March 6, 2013 - 8:00 AM EST

ScripsAmerica on Pace to Achieve Significant Revenue Growth in 2013 With Consecutive Record-Setting Months
NEW CASTLE, Del., March 6, 2013 (GLOBE NEWSWIRE) -- ScripsAmerica Inc. (OTCBB:SCRC), a leading supplier of prescription, OTC and nutraceutical drugs, today announced that the Company recorded its highest February revenue ever at $849,039, representing a 115% increase over February 2012.

In January, ScripsAmerica recorded its highest monthly revenue ever at $904,275 and its strong February sales put the Company on pace to achieve over $10,000,000 in revenue for 2013, which would represent a growth rate of 68% or higher over last year. With the anticipated product launch of its RapiMed® pediatric pain and fever reliever and acquisition of its pharmaceutical repackager, Marlex Pharmaceuticals, the Company expects to continue its steady growth.

"We are pleased to report a record start of 2013 to our shareholders, which management believes will be a breakout year for the company. ScripsAmerica is on pace to record our highest annual revenue ever and achieve an important milestone of $10 million in revenue. With our planned developments for the rest of this year, we are confident in our ability to continue this high rate of growth," stated CEO of ScripsAmerica, Bob Schneiderman. ...... http://app.quotemedia.com/quotetools/newsStoryPopup.go?storyId=58530891&topic=SCRC&symbology=null&cp=off&webmasterId=89753